Keywords: Asthma, COPD, Bronchiectasis, Biologic treatments, Mepolizumab, Reslizumab, Benralizumab, Dupilumab, Tezepelumab, Th2-inflammation, Eosinophilic inflammation, Treatable traits, Precision ...